Article Details
Retrieved on: 2021-05-26 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
WARMINSTER, Pa., May 26, 2021 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical ...
Article found on: financialpost.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here